THE Therapeutic Goods Administration (TGA) is warning consumers that AB-Slim Slim-cellulose capsules pose a serious risk to their health.
Tests on the product found the capsules contain undeclared quantities of prescription-only substance, sibutramine.
Consumers have been advised to take remaining capsules to their local pharmacy for safe disposal.
The TGA is working with the Australian Border Force to help stop future shipments of AB-Slim capsules from entering Australia.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Aug 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Aug 21